North America Used Cooking Oil Market

ID: MRFR/FnB/63901-HCR
128 Pages
Pradeep Nandi
Last Updated: April 06, 2026
North America Used Cooking Oil Market Size, Share, Industry Trend & Analysis Research Report By Source (Food Manufacturers, HoReCa, Household, Others) and By Application (Biodiesel, Oleochemical Products, Animal Feed, Others)-Forecast to 2035
North America Used Cooking Oil Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)5.86%
2024 Market Size$ 3,100 Million
2025 Market Size$ 3,281.66 Million
2035 Market Size$ 5,800 Million
Key Players
Bunge Limited
Cargill
Incorporated
Archer Daniels Midland Company
Wilmar International Limited
Louis Dreyfus Company
Opportunities
  • Regulatory Support for Waste Management
  • Growing Awareness of Environmental Impact
  • Rising Demand for Renewable Energy Sources
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Pharmaceutical, BY Application (USD Million)
      1. 4.1.1 Biodiesel Production
      2. 4.1.2 Animal Feed
      3. 4.1.3 Industrial Lubricants
      4. 4.1.4 Soaps and Detergents
    2. 4.2 Pharmaceutical, BY End Use (USD Million)
      1. 4.2.1 Transportation Fuels
      2. 4.2.2 Food Industry
      3. 4.2.3 Renewable Energy
    3. 4.3 Pharmaceutical, BY Source (USD Million)
      1. 4.3.1 Restaurants
      2. 4.3.2 Food Processing Industries
      3. 4.3.3 Households
    4. 4.4 Pharmaceutical, BY Processing Method (USD Million)
      1. 4.4.1 Physical Refining
      2. 4.4.2 Chemical Refining
      3. 4.4.3 Blending
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Pharmaceutical
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Bunge Limited (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Cargill, Incorporated (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Archer Daniels Midland Company (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Wilmar International Limited (SG)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Louis Dreyfus Company (NL)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Noble Group Limited (SG)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Mewah Group (SG)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Austrian Oil and Gas (AT)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 NORTH AMERICA MARKET ANALYSIS BY APPLICATION
    3. 6.3 NORTH AMERICA MARKET ANALYSIS BY END USE
    4. 6.4 NORTH AMERICA MARKET ANALYSIS BY SOURCE
    5. 6.5 NORTH AMERICA MARKET ANALYSIS BY PROCESSING METHOD
    6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
    9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
    11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
    12. 6.12 PHARMACEUTICAL, BY APPLICATION, 2024 (% SHARE)
    13. 6.13 PHARMACEUTICAL, BY APPLICATION, 2024 TO 2035 (USD Million)
    14. 6.14 PHARMACEUTICAL, BY END USE, 2024 (% SHARE)
    15. 6.15 PHARMACEUTICAL, BY END USE, 2024 TO 2035 (USD Million)
    16. 6.16 PHARMACEUTICAL, BY SOURCE, 2024 (% SHARE)
    17. 6.17 PHARMACEUTICAL, BY SOURCE, 2024 TO 2035 (USD Million)
    18. 6.18 PHARMACEUTICAL, BY PROCESSING METHOD, 2024 (% SHARE)
    19. 6.19 PHARMACEUTICAL, BY PROCESSING METHOD, 2024 TO 2035 (USD Million)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY APPLICATION, 2025-2035 (USD Million)
      2. 7.2.2 BY END USE, 2025-2035 (USD Million)
      3. 7.2.3 BY SOURCE, 2025-2035 (USD Million)
      4. 7.2.4 BY PROCESSING METHOD, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

North America Pharmaceutical Market Segmentation

Pharmaceutical By Application (USD Million, 2025-2035)

  • Biodiesel Production
  • Animal Feed
  • Industrial Lubricants
  • Soaps and Detergents

Pharmaceutical By End Use (USD Million, 2025-2035)

  • Transportation Fuels
  • Food Industry
  • North America Used Cooking Oil Market

Pharmaceutical By Source (USD Million, 2025-2035)

  • Restaurants
  • Food Processing Industries
  • Households

Pharmaceutical By Processing Method (USD Million, 2025-2035)

  • Physical Refining
  • Chemical Refining
  • Blending
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.